/PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious.
This article reviews the essential regulatory considerations surrounding medicines and medical devices in Brazil, including clinical trials and marketing authorisations.